patient’s problems - vumc · pdf filepatient’s problems ... some bedside clinical...
TRANSCRIPT
![Page 1: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/1.jpg)
Patient’s Problems • Pain (80%) • Fatigue (90%) • Weight Loss (80%) • Lack of Appetite (80%) • Nausea, Vomiting (90%) • Anxiety (25%) • Shortness of Breath (50%) • Confusion-Agitation (80%)
![Page 2: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/2.jpg)
![Page 3: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/3.jpg)
Tumor Edema
![Page 4: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/4.jpg)
Suzuki, et al in (Bruera, Portenoy – Cancer Pain
![Page 5: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/5.jpg)
Suzuki, et al in (Bruera, Portenoy – Cancer Pain
![Page 6: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/6.jpg)
Inhibitory Modulators of Nociception 1. [Opioids peripheral and central]. 2. Adrenergic – Serotonergic [Tricyclics,
SSRIs, Tramadol]. 3. GABA pathway [analogs too toxic]. 4. Adenosyn [decreased plasma and CSF
adenosyn levels in neuropathic pain].
![Page 7: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/7.jpg)
Excitatory Modulation of Nociception • NMDA receptors [glutamate, excitatory AAs]. • Effective in neuropathic pain in animals. • Prevent and reverse morph intolerance.
![Page 8: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/8.jpg)
Hyperalgesia – exaggerated response to noxious stimulus
Hyperesthesia – exaggerated response to touch
Allodynia – perceiving a non-nociceptive stimulus as painful
![Page 9: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/9.jpg)
Intensity assessment
0- 10 numerical scales Visual analogue scales Verbal scales Face scales Color scales Finger scales
Dr. Bruera
![Page 10: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/10.jpg)
ESAS (Edmonton Symptom Assessment System)
2 minutes by patient in the waiting room
Well validated
Most common tool in cancer and palliative care
FREE!!!. Download it today and start using it!
Dr. Bruera
![Page 11: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/11.jpg)
Symptom Assessment Edmonton Symptom Assessment Scale (ESAS)
Average intensity of 10 symptoms over past 24 hours
Numeric rating scale Physical (N=7) Emotional (N=2) Well being (N=1)
Bruera et al. J Palliat Care 1991
Dr. Bruera
©Permission to reuse given by Dr. Bruera
![Page 12: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/12.jpg)
SYMPTOM ASSESSMENT – DAY 1
![Page 13: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/13.jpg)
SYMPTOM ASSESSMENT – DAY 8
![Page 14: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/14.jpg)
![Page 15: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/15.jpg)
![Page 16: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/16.jpg)
Schema of Symptom Construct
1. PRODUCTION/CONSTRUCT
2. PERCEPTION
3. EXPRESSION
MODULATION
COGNITIVE STATUS
MOOD
BELIEFS
CULTURAL
BIOGRAPHY TREATMENT
Dr. Bruera
![Page 17: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/17.jpg)
PC Assessment
Pain is a Multidimensional Construct
Dr. Bruera
What’s in a name?
What’s in a number?
PAIN
0-10
![Page 18: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/18.jpg)
What Impacts Pain Intensity 0-10?
Afferent Nociception Meaning (Cancer, Osteoporosis?) Personality (Stoic, Histrionic?) Experience/Memory (Father died in pain) Alcoholism/Drugs (Chemical coping) Intelligence/Education (Understands pain & treatment) Culture (Pain expression OK?) Spirituality (Pain Good? Punishment?) Secondary Gain (Attention from family) Depression/Anxiety (Somatization) Delirium (Disinhibition) Trust In Doctors (Adherence, Placebo!)
Dr. Bruera
![Page 19: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/19.jpg)
Pain Intensity 8/10
Dr. Bruera
Patient #1 Patient #2 Nociception 85% 30% Somatization 5% 20% Coping Chemically 5% 30%
Tolerance 5% 0% Incidental Pain 0% 20%
100% 100%
![Page 20: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/20.jpg)
PC Assessment
Fatigue 8/10 Patient 1 Patient 2
Depression 60% 10%
Cachexia 10% 50%
Anemia 10% 30%
Opioids 20% 0%
Autonomic 0% 10%
![Page 21: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/21.jpg)
PC Assessment
![Page 22: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/22.jpg)
NCCN guidelines: Pain>7: Pain emergency! Median intensity of pain reported by chronic non malignant pain patients attending outpatient clinics: 7.2 What’s in a name? What’s in a number?
![Page 23: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/23.jpg)
Personalized Pain Goal
445 cancer patients at Supportive Care Center Median follow-up 14 days
Dalal et al. Cancer 2012
Dr. Bruera
Cancer by AMERICAN CANCER SOCIETY Reproduced with permission of JOHN WILEY & SONS - JOURNALS in the format Post in a course management system via Copyright Clearance Center.
![Page 24: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/24.jpg)
Personalized Pain Goal A Tale of Two Patients
Dalal et al. Cancer 2012
At what level of pain would YOU feel comfortable?
Patient 1
Patient 2
Dr. Bruera
![Page 25: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/25.jpg)
ASK Personal Pain Goal! (≈ 3/10 for Assessment)
Number is only part of the assessment
Function more important
Refer patients who continue to express high levels of pain intensity to Supportive Care/Palliative Care team
Dr. Bruera
![Page 26: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/26.jpg)
PC Assessment
↑ Pain Intensity
Chemical Coping
Ischemia
Tumor Growth Infection
Opioid Tolerance Delirium
Fracture
Mood Change
Cancer Related
Patient Related Dr. Bruera
Pain Intensity
![Page 27: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/27.jpg)
Prognostic Features
Some bedside clinical findings are associated with worse response to pain management
Dr. Bruera
![Page 28: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/28.jpg)
The Five Poor Pain Prognostic Features
Neuropathic
Incidental ( BTP)
Delirium
Somatization
Chemical coping
Dr. Bruera
![Page 29: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/29.jpg)
Pathophysiology
Neuropathic
Incident
Dr. Bruera
![Page 30: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/30.jpg)
Neuropathic
Brachial plexopathy (breast, lung)
Lumbosacral plexopathy (retroperitoneal or pre- sacral tumor)
Lower response rate to opioids
Opioids remain first line to therapy!
Dr. Bruera
![Page 31: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/31.jpg)
PC Assessment
Incident Pain
Nociceptive input is variable
Analgesic modulation is slower
Movement, swallowing, cough, bowel movement
Few to several hundred episodes/day
Rapid onset and termination
Dr. Bruera
![Page 32: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/32.jpg)
Increased Expression
Delirium disinhibition
Chemical coping
Somatization (“total pain”)
Dr. Bruera
![Page 33: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/33.jpg)
Delirium
Sepsis
Chemo
OPIOIDS and other drugs (psych!!)
Tumor byproducts and host cytokines
Metabolic Na, Ca, Creat
CNS Involvement
Dehydration
Dr. Bruera
Delirium
![Page 34: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/34.jpg)
PC Assessment
Delirium
85% cancer patients before death
Multi-causal
80% of brain is GABA
Disinhibition: expression of symptoms and emotions
Dr. Bruera
![Page 35: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/35.jpg)
Delirium
Opioids can cause- dose escalation!!
Increased pain: hyperalgesia /delirium
Screening!! Mini-Mental State Examination, hallucinations, agitation
Dr. Bruera
![Page 36: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/36.jpg)
Delirium and Symptom Expression (Delgado- Guay)
A 60 year old man with advanced small cell prostate cancer, lumbar adenophathies and bone metastases.
Dr. Bruera
Chemotherapy + lumbar radiotherapy Referred STAT due to severe pain
Admission: calcium 12.44, creatinine 1.6 Pain 9, MDAS 14
Bedridden
![Page 37: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/37.jpg)
ESAS Findings at Admission
Delgado-Guay MO, et al. JPSM 2008; 36(4):442-449
Dr. Bruera
![Page 38: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/38.jpg)
Somatization
“total pain”, “total suffering”
Diagnostic criterion for affective disorders
Meaning of pain for the patient
Aggravated by stressors
High intensity expression (10/10)
Multiple symptoms (“all black graph”)
Dr. Bruera
![Page 39: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/39.jpg)
Somatization
Intensity – 10 PPG - 0
Reason for Concern
Dr. Bruera
![Page 40: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/40.jpg)
Chemical Coping
Using the opioid (and other psychoactive drugs) to cope with distress rather than pain
Approximately 1/ 5 cancer patients
The vast majority underdiagnosed until aberrant opioid use detected
Dr. Bruera
![Page 41: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/41.jpg)
Opioid
MOR Nociceptive Pathway
Nociceptive Input
Excitatory Amino Acids Fast ! Slow !
PAIN + −
Dr. Bruera
![Page 42: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/42.jpg)
Opioid
MOR limbic System
Distresss
Fast !
Non Opioid
Pathways
+
−
Fast !
Dr. Bruera
![Page 43: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/43.jpg)
![Page 44: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/44.jpg)
Methods
• 432 outpatients seen at SCC • 13 PM specialists assessed for cc all pts
they had seen for the last 40 days • Review of documentation in chart
![Page 45: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/45.jpg)
Results
• 76/432 pts (18%) diagnosis of Chemical coping by pall med specialist
• Only 15/432 (4%) documented CC in the chart !!
![Page 46: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/46.jpg)
![Page 47: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/47.jpg)
CAGE (AID) Questionnaire
• Have you ever felt that you should cut down on your drinking (or drugs)?
• Have you ever been annoyed by people criticizing your drinking (or drugs)?
• Have you ever felt bad or guilty about your drinking ( or drugs)?
• Have you ever had a drink first thing in the morning or a drink ( or drugs) to get rid of a hangover (eye-opener)?
![Page 48: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/48.jpg)
Why should you care about CAGE ? • Marker for chemical coping, NOT just
ETOH!! • ETOH shares reward with opioids • MDs do not diagnose chemical coping- dose
escalation and OIN • Counseling helps reduce conflict and dose
![Page 49: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/49.jpg)
![Page 50: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/50.jpg)
![Page 51: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/51.jpg)
Opioid management
• Document chemical coping/ aberrant opioid use ( sensitive notes)
![Page 52: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/52.jpg)
Smoking is a risk factor (Kim, Dev, et al JPSM 2016
• 300 consecutive cancer pts comprehensive smoking assessement:
• 119 (40%) never smokers, 148 (49%) former smokers and 33 (11%) current smokers
• CAGE +: 3%, 12%, 42% • Hx drugs +: 3%, 16%, 33%
![Page 53: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/53.jpg)
![Page 54: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/54.jpg)
2. Assess Pain Characteristics Location Medical treatments Number of episodes Onset Position Quality Radiation Severity Triggers Identification of pain mechanism
3. Assess Pain Modulators Somatization ( psychological/ spiritual) Chemical coping Delirium
5. Formulate Personalized Pain Treatment Plan Analgesia—based on pain mechanism, individual preference, past treatment history Psychological distress—counseling Spiritual distress—pastoral care Chemical coping—education, focus on function, close monitoring Cognitive impairment—treat underlying cause (e.g. opioid rotation), neuroleptics
6. Regular Reassessment Duration of follow-up is individualized based on complexity, generally 1-4 weeks Personalized pain goal achieved? Medication side effects, adherence and aberrant behaviors
Hui and Bruera. J Clin Oncol 2014 (in press)
Personalized Pain Management
Dr. Bruera
1. Routine Pain Screening From 0 to 10, what is your level of pain over the last 24 hours?
4. Assess Personalized Pain Goal From 0 to 10, at what level do you feel comfortable?
![Page 55: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/55.jpg)
PC Assessment
Patient Understanding
Addiction
Pain escalation in the future
Opioids as the cause of death
Fear of side effects
Regular vs. PRN
Dr. Bruera
![Page 56: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/56.jpg)
Opioid Titration/Rotation
Opioid naïve patient → EASY!!
Always starting dose
Intensity of pain expression is not important consideration – Safety is the main reason for always using standard dose: – ≡ 30 mg morphine/day orally – 20 oxycodone (hydrocodone, etc.)
Dr. Bruera
![Page 57: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/57.jpg)
Which Opioid?
Good kidney, good liver, no other drugs → all good
Dr. Bruera
![Page 58: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/58.jpg)
Opioid
Phase I: Oxydation Hydrolysis 3A4 – 2D6
Phase II: Conjugation UGD
Renal Elimination
Dr. Bruera
Opioid metabolism
![Page 59: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/59.jpg)
Phase I (* = Active) Morphine * Hydromorphone * Oxymorphone * Tapentadol * Codeine Hydrocodone* Oxycodone* Tramadol Fentanyl* Methadone*
0 0 0 0 ? 2D6 Morphine* 3A4 Norcodeine 2D6 Hydromorphone* 3A4 Norhydrocodone 3A4 Noroxycodone 2D6 Oxymorphone* 2D6 O-demethyl-T* 3A4 N-demethyl-T* 3A4 Norfentanyl 3A4 M1 – M2
Dr. Bruera
![Page 60: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/60.jpg)
3A4
Macrolides
Fluroquinolones
Azoles
Antiretrovirals
Grapefruit
Imatinib – Irinotecan
New targeted agents
Dr. Bruera
![Page 61: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/61.jpg)
2D6
SSRIs
Genetic Poor Metabolizers
Neuroleptics (Haloperidol – Chlorpromazine)
Dr. Bruera
![Page 62: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/62.jpg)
Clinical Implications
Sedation New Drugs 3A4? (Methadone, Fentanyl, Oxycodone, Hydrocodone, Tramadol, Codeine)
No Response to codeine, tramadol: Slow 2D6, SSRI, Neuroleptic
Sedation Renal Failure? (Morphine, Hydromorphone, Oxymorphone, Oxycodone)
Sedation Liver Failure? (Methadone, Fentanyl)
Dr. Bruera
![Page 63: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/63.jpg)
Cleaner opioids (No major 2DG – 3A4 metabolism)
Morphine
Hydromorphone
Oxymorphone
Dr. Bruera
![Page 64: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/64.jpg)
Potential toxicity in patients with Fluconazole, macrolides, quinolones, anti retrovirals, etc.
Methadone
Fentanyl
Oxycodone
Hydrocodone
Dr. Bruera
3A4 METABOLISM
![Page 65: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/65.jpg)
Less effects in patients on SSRIs, haloperidol, genetically poor metabolizers
Codeine
Dr. Bruera
2D6 Activation
![Page 66: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/66.jpg)
Methadone
Probably fentanyl
Hydromorphone
Dr. Bruera
Renal Failure
![Page 67: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/67.jpg)
Clean ones
Morphine
Hydromorphone
Oxymorphone
Dr. Bruera
Liver Failure
![Page 68: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/68.jpg)
Extended Release or Immediate Release?
Dr. Bruera
![Page 69: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/69.jpg)
Ideal Regime
Extended release regularly
PRN orally immediate-release opioid ≈ 5%- 20% of the daily dose
Always 100% laxative
Always PRN Antiemetic (especially first 3 days, metoclopramide)
Dr. Bruera
![Page 70: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/70.jpg)
Characteristics of patients with consult only vs. consult plus follow up visit
![Page 71: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/71.jpg)
Median ESAS scores at baseline and first follow up visits
![Page 72: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/72.jpg)
Percentage of patients having pain treatment response and percentage of patients with good pain control (pain ≤3/10) at first follow up visit
![Page 73: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/73.jpg)
Follow-Up: Phone/See ≤ 1 week
Dr. Bruera
![Page 74: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/74.jpg)
Minimal Increase/ decrease ≈ 30% of daily dose ( opioid titration always % due to large dose range!!)
Dr. Bruera
![Page 75: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/75.jpg)
• Rapid dose escalation: hyperalgesia!! • Opioid induced neurotoxicity • Financial cost (USA) • Rarely other side effects ( nausea,
constipation)
When do we rotate?
![Page 76: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/76.jpg)
Delirium
Sepsis
Chemo
3 Cyclics, Benzodiazepines
Opioids
Metabolic Na, Ca, Creat
CNS Involvement
Dehydration
![Page 77: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/77.jpg)
To which opioid? → NOT IMPORTANT!! Stopping the offending opioids IS IMPORTANT
Dr. Bruera
![Page 78: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/78.jpg)
How Do We Rotate?
A. Calculate MEDD (Morphine Equivalent Daily Dose) 260 regular + 60 mg BTP → 320 mg/day
B. Equianalgesic Ratio (from table) For hydromorphone MEDD/ 5 → ≈ 60 mg/day For oxycodone MEDD/ 1.5 → ≈ 200 mg/day For oxymorphone MEDD/ 3 → ≈ 100 mg/day
C. DOSE REDUCTION! Due to incomplete cross tolerance (30% – 50%)
D. New Opioid and Dose: ER Hydromorphone 30 mg daily orally IR Hydromorphone 2mg-4mg every hour PRN
Phone/see patient in 2-3 days to further titrate – large interpersonal variation!!
Dr. Bruera
![Page 79: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/79.jpg)
Relationship Between Hydromorphone & Morphine
Dr. Bruera
Image provided by Dr. Bruera
![Page 80: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/80.jpg)
Patient unable to swallow
Admit the patient and change to parenteral opioid A. All opioids except methadone need continuous
infusion! (short half life)
B. Correct dose from PO to parenteral ratio from tables (orally given has first passage elimination and intravenous [IV] avoids liver). For most opioids oral/IV ratio is 2-3:1
Dr. Bruera
![Page 81: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/81.jpg)
Dr. Bruera
C. Rescue dose also is IV/SC approximately 10% daily dose or about two hours of infusion
D. Assess Daily → Steady state of IV opioid reached in ≤ 24 hours! – increase or decrease 30% – 50%
Patient Case Continued
![Page 82: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/82.jpg)
When IV Route Not Possible or Comfortable
Subcutaneous intermittent injection every four hours into an indwelling butterfly needle (morphine, hydromorphone), or every 8 to 12 hours for methadone
Fentanyl (too short half life) will need a subcutaneous continuous infusion
Dr. Bruera
![Page 83: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/83.jpg)
When Pain severe, neurotoxicity severe or patient has financial problems: METHADONE!!
Dr. Bruera
![Page 84: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/84.jpg)
Extraordinary results but potential for severe toxicity if medical doctor unfamiliar. NMDA receptor blocker → less hyperalgesia Much more potent Much cheaper More dangerous in tolerant patients Every 12 hours and once in steady stage can be used also
for BTP Subcutaneous/IV can be used every 12 hours (long half life) QT prolongation reported & EKG good idea before starting
IV and after three to five days We do not find QT prolongation orally and do not regularly
do EKG for methadone rotation
Dr. Bruera
All Other Opioids: Toyotas or Hondas Methadone: Lamborghini
![Page 85: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/85.jpg)
Oral Methadone in Cancer Pain
Dr. Bruera
Pain by INTERNATIONAL ASSOCIATION FOR THE STUDY OF PAIN Reproduced with permission of ELSEVIER HEALTH SCIENCE JOURNALS in the format Post in a course management system via Copyright Clearance Center.
Lawlor P et al. Pain 1997 72(1-2):79-85
![Page 86: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/86.jpg)
Conclusions
Use only a few opioids so you are quite familiar with them
Titration, rotation, and route change to and from are simple if you follow a checklist
Remember interpersonal variations:
Follow-Up Frequently
Dr. Bruera
![Page 87: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/87.jpg)
Opioid Side Effects Common • Sedation • Constipation • Nausea
Less Common • Opioid-induced neurotoxicity • Sweating • Urinary Retention • Pruritus • Adult Respiratory Distress Syndrome • Addiction • Respiratory Depression • Hypogonadism
![Page 88: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/88.jpg)
Managing side effects
• 100% laxative and titrate to regular bowel movement
• 100% metoclopramide 10 mg po q4h prn • Phone if more than >3- 4 BTP doses per day • Stop and phone if too sleepy/ confused
![Page 89: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/89.jpg)
Drugs For Opioid-Induced Constipation
FDA Approved: Methylnaltrexone: Periph mu Antag Lubiprostone: Chloride Channel Activator Naloxegol: Periph mu Antag Almivopan: Periph mu Antag (Not for Opioids!)
In Research: Axelopran: Periph mu Antag Sustained release Naloxone: mu Antag (periph x central)
![Page 90: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/90.jpg)
ALTERNATE ROUTES
ESTABLISHED • Subcutaneous • Rectal • Transdermal • Transmucosal
EMERGING • Intranasal • Inhalatory • Sublingual • Transdermal -
iontophoresis
![Page 91: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/91.jpg)
Parenteral opioids
• IV always infusion for morphine, hydromorphone, fentanyl, oxycodone (very short half life!)
• Intermittent IV: methadone q 12 h ( EKG need controversial, not in hospice or when not available
• BT dose: 10% of daily infusion • SC: intermittent injection
![Page 92: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/92.jpg)
When IV Route Not Possible or Comfortable
Subcutaneous intermittent injection every 4 hours into an indwelling butterfly needle (morphine, hydromorphone), or every 8 to 12 hours for methadone
Fentanyl (too short half life) will need a subcutaneous continuous infusion
![Page 93: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/93.jpg)
Abuse deterrent formulations
1. Tamper proof ( cannot be chewed/ injected). 2. Mixed with antagonist (naloxone, naltrexone) 3. Mixed with local irritants (pain upon snorting/
injection, or niacin (flushing, nausea, headache) • Will reduce street value, but will NOT prevent the
main issue with chemical coping: taking too much!
• Do not address IR rescue opioid • Very expensive
![Page 94: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/94.jpg)
Pathophysiology poor prognostic factors • Neuropathic • Incidental
![Page 95: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/95.jpg)
Neuropathic
• Non cancer ( periph neuropathy, post herpetic): >65% response to non opioids
• Cancer ( brachial, lumbosacral pexopathy): < 30 % response to non opioids, >60% response to opioids
Allodynia, “burning”, “pins and needles”, radiation : frequent but not necessary!!
![Page 96: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/96.jpg)
INCIDENTAL PAIN – Clinical Aspects
• Main Pain Problem for the Patient (Intensity) • Range: 1 - 3000 times/day • Duration: Seconds - One Hour • Causing Factor: Present (movement) or Absent (Neuralgic)
![Page 97: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/97.jpg)
PC Assessment
Incident pain
• 1. Nociceptive input is variable. • 2. Analgesic modulation is slower • 3. Movement, swallowing, cough, bowel
movement • Few to several hundred episodes/ day • Rapid onset and termination
![Page 98: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/98.jpg)
PC Assessment
Incidental pain- Strategies
• Decrease nociceptive input- XRT, bisphosphonates, nerve block
• Psychostimulants • Adjuvants
![Page 99: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/99.jpg)
• RCT, Double-blind, Placebo • Tolerant to 60-1000 mg/ day • Open Label Titration!! • 80/123 Responded (65%!!)
![Page 100: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/100.jpg)
11/05/2012
![Page 101: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/101.jpg)
![Page 102: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/102.jpg)
• What happened to intention to treat? • Loading the dice ( placebo control) • Falls, Cognition, Addiction
![Page 103: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/103.jpg)
![Page 104: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/104.jpg)
![Page 105: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/105.jpg)
11/05/2012
![Page 106: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/106.jpg)
11/05/2012
![Page 107: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/107.jpg)
11/05/2012
![Page 108: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/108.jpg)
• No Cross-over, No Patient Choice • “Efficacious and Safe” • Efficacious? : 3.02 versus 2.69! • Safe? Falls, Cognitive, Addiction!!
![Page 109: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/109.jpg)
6. The opioid access story
• Most cancer patients die without a single opioid dose
![Page 110: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/110.jpg)
Distribution of Morphine Consumption in 2009
![Page 111: Patient’s Problems - VUmc · PDF filePatient’s Problems ... Some bedside clinical findings are associated ... UGD . Renal . Elimination . Dr. Bruera . Opioid metabolism](https://reader034.vdocument.in/reader034/viewer/2022051720/5a78a9497f8b9a21538b8782/html5/thumbnails/111.jpg)
OPIOID COSTS MEDD 100 mg/day Cost of
Opioid,U$ Opioid Cost as % of monthly GNP/capita
Cost of Morphine
Morphine cost as % of
monthly GNP
Number of observations
Developing Developed
45 76
45 76
13 20
13 20
Mean (Standard deviation)
Developing Developed
828 (1711) 127 (189)
267 (534) 7 (12)
463 (910) 71 7(1)
148 (313) 4 (4)
Median (range) Developing Developed P value
112 (4-7542) 53 (2-103) =0.02
36 (3-2262) 3 (<1-65) <0.0001
108 (4-3240) 52 (2-305) >0.02
38 (3-1170) 3 (<1-14) =0.0003